No Data
Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug With an Estimated Global Market of $2.5 Billion
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
Sunshine Biopharma Stock Shoots Higher On Encouraging Data From MRNA-Based Liver Cancer Drug
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Sunshine Biopharma Announces Positive Results of MRNA Therapy for Cancer
